HLA-C and cancer: Although the immune system is able to recognize and destroy cancer cells, malignant cells can develop different mechanisms aimed at evading the host’s immune control, by reducing MHC complex expression on APCs or inhibiting the immune response (immune checkpoint molecules) [24,25].